TBK1‐Associated Primary Lateral Sclerosis Followed by Right Temporal Variant Frontotemporal Dementia
ABSTRACT We report a 58‐year‐old woman with a novel splice‐site variant in the TANK‐binding kinase 1 (TBK1:c.993–2A>C p.Ala332TyrfsTer39) who sequentially developed primary lateral sclerosis (PLS) followed by right temporal variant frontotemporal dementia (rtvFTD). Neuroimaging demonstrated right anterior temporal atrophy before cognitive symptoms, and
Tomoyasu Matsubara +18 more
wiley +1 more source
<i>Lepidium virginicum</i> Water-Soluble Chlorophyll-Binding Protein with Chlorophyll A as a Novel Contrast Agent for Photoacoustic Imaging. [PDF]
Tsang VTC +4 more
europepmc +1 more source
MRI contrast agent(gadolinium based MRI contrast agent)
openaire +2 more sources
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown +6 more
wiley +1 more source
Magnetic resonance vasography using paramagnetic contrast agent - a case report. [PDF]
Rzymkowski F +4 more
europepmc +1 more source
Novel multifunctional targeted nanozyme as an ultrasound contrast agent for real-time monitoring and treatment of congenital hydronephrosis renal fibrosis. [PDF]
Zhao Q, Zhang D, Chen K, Sun F, Chen Y.
europepmc +1 more source
Preliminary study on the use of perfluoropropane contrast agent in monitoring drug diffusion during fascial plane blocks. [PDF]
Zhang Z +5 more
europepmc +1 more source
Toward the clinical translation of safe intravenous long circulating ILNEs contrast agent for CT imaging. [PDF]
Attia MF +6 more
europepmc +1 more source
Water-soluble contrast agent use in adhesional small bowel obstruction: a survey of surgical practices and clinical trial considerations. [PDF]
Aimar K +5 more
europepmc +1 more source

